[Federal Register Volume 82, Number 66 (Friday, April 7, 2017)]
[Notices]
[Pages 17012-17013]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06938]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-0001]


Preparation for International Cooperation on Cosmetics Regulation 
Eleventh Annual Meeting; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing a 
public meeting entitled ``International Cooperation on Cosmetics 
Regulation (ICCR)--Preparation for ICCR-11 Meeting.'' The purpose of 
the meeting is to invite public input on various topics pertaining to 
the regulation of cosmetics. We may use this input to

[[Page 17013]]

help us prepare for the ICCR-11 meeting that will be held July 12-14, 
2017, in Brasilia, Brazil.

DATES: The public meeting will be held on May 25, 2017, from 2 p.m. to 
4 p.m. See the SUPPLEMENTARY INFORMATION section for registration date 
and information.

ADDRESSES: The public meeting will be held at the Food and Drug 
Administration, Center for Food Safety and Applied Nutrition, 5001 
Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740.

FOR FURTHER INFORMATION CONTACT: Jonathan Hicks, Office of Cosmetics 
and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-125), 
College Park, MD 20740, email: [email protected], 240-402-
1375.

SUPPLEMENTARY INFORMATION:

I. Background

    The purpose of the multilateral framework on the ICCR is to pave 
the way for the removal of regulatory obstacles to international trade 
while maintaining global consumer protection. The purpose of the 
meeting is to invite public input on various topics pertaining to the 
regulation of cosmetics. We may use this input to help us prepare for 
the ICCR-11 meeting that will be held July 12-14, 2017, in Brasilia, 
Brazil.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from Brazil, Canada, the European Union, Japan, and the 
United States of America. These regulatory authority members will enter 
into constructive dialogue with their relevant cosmetics industry trade 
associations and public advocacy groups. Currently, the ICCR members 
are: The Brazilian Health Surveillance Agency; Health Canada; the 
European Commission Directorate-General for Internal Market, Industry, 
Entrepreneurship, and Small and Medium-sized Enterprises; the Ministry 
of Health, Labor, and Welfare of Japan; and FDA. All decisions made by 
consensus will be compatible with the laws, policies, rules, 
regulations, and directives of the respective administrations and 
governments. Members will implement and/or promote actions or documents 
within their own jurisdictions and seek convergence of regulatory 
policies and practices. Successful implementation will need input from 
stakeholders.

II. Topics for Discussion at the Public Meeting

    We will make the agenda for the public meeting available on the 
Internet at http://www.fda.gov/Cosmetics/InternationalActivities/ICCR/default.htm. Depending on the number of requests for oral 
presentations, we intend to have an agenda available by May 18, 2017.

III. Participating in the Public Meeting

    Registration: To register for the public meeting, send registration 
information (including your name, title, affiliation, address, email, 
and telephone), to Jonathan Hicks by May 11, 2017. If you would like to 
listen to the meeting by phone, please submit a request for a dial-in 
number by May 11, 2017. If you need special accommodations due to a 
disability, please contact Jonathan Hicks by May 18, 2016.
    Requests for Oral Presentations: If you wish to make an oral 
presentation, you should notify Jonathan Hicks by May 11, 2017, and 
submit a brief statement of the general nature of the evidence or 
arguments that you wish to present, your name, title, affiliation, 
address, email, and telephone, and indicate the approximate amount of 
time you need to make your presentation. You may present proposals for 
future ICCR agenda items, data, information, or views, in person or in 
writing, on issues pending at the public meeting. There will be no 
presentations by phone. Time allotted for oral presentations may be 
limited to 10 minutes or less for each presenter.
    Transcripts: Please be advised that as soon as a transcript of the 
public meeting is available, it will be accessible at https://www.regulations.gov. It may also be viewed at the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20850.

    Dated: April 3, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-06938 Filed 4-6-17; 8:45 am]
 BILLING CODE 4164-01-P